Bridgewater Associates Lp buys $28,370,470 stake in AmerisourceBergen Corp. (ABC)

AmerisourceBergen Corp. (ABC) : Bridgewater Associates Lp scooped up 75,100 additional shares in AmerisourceBergen Corp. during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 10, 2016. The investment management firm now holds a total of 319,092 shares of AmerisourceBergen Corp. which is valued at $28,370,470.AmerisourceBergen Corp. makes up approximately 0.33% of Bridgewater Associates Lp’s portfolio.

Other Hedge Funds, Including , First Mercantile Trust Co reduced its stake in ABC by selling 10,612 shares or 54.74% in the most recent quarter. The Hedge Fund company now holds 8,774 shares of ABC which is valued at $780,096. AmerisourceBergen Corp. makes up approx 0.09% of First Mercantile Trust Co’s portfolio.Brown Advisory Inc reduced its stake in ABC by selling 183 shares or 0.35% in the most recent quarter. The Hedge Fund company now holds 52,276 shares of ABC which is valued at $4,635,313. AmerisourceBergen Corp. makes up approx 0.02% of Brown Advisory Inc’s portfolio.Bank Of Hawaii reduced its stake in ABC by selling 7,102 shares or 64.83% in the most recent quarter. The Hedge Fund company now holds 3,852 shares of ABC which is valued at $346,256. AmerisourceBergen Corp. makes up approx 0.04% of Bank Of Hawaii’s portfolio. Newsquare Capital sold out all of its stake in ABC during the most recent quarter. The investment firm sold 200 shares of ABC which is valued $17,084. Martin Investment Management sold out all of its stake in ABC during the most recent quarter. The investment firm sold 160,974 shares of ABC which is valued $13,821,228.

AmerisourceBergen Corp. closed down -0.12 points or -0.13% at $88.85 with 20,89,408 shares getting traded on Friday. Post opening the session at $88.53, the shares hit an intraday low of $88.26 and an intraday high of $89 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, AmerisourceBergen Corp. reported $1.37 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.27. The company had revenue of $36900.00 million for the quarter, compared to analysts expectations of $36705.18 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS.

Many Wall Street Analysts have commented on AmerisourceBergen Corp.. Company shares were Reiterated by Mizuho on Aug 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 90 from a previous price target of $80 .Company shares were Reiterated by FBR Capital on Aug 3, 2016 to “Mkt Perform”, Firm has raised the Price Target to $ 90 from a previous price target of $84 .Company shares were Reiterated by Barclays on Aug 3, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 89 from a previous price target of $83 .

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally the Company offers healthcare providers and pharmaceutical manufacturers with services including reimbursement and pharmaceutical consulting services logistics services inventory management pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

Leave a Reply

AmerisourceBergen Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on AmerisourceBergen Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.